GXP Engaged’s acquisition of SwissPharmAudit GmbH accelerates global growth, increasing penetration and reach particularly in Northern Europe and Switzerland, further establishing our position as the market leading provider of GxP quality assurance and consulting services. With nearly 300 highly experienced, fully qualified auditors and coverage of 65+ countries, we provide clients with access to exceptional auditing services across the globe.
With specialist expertise in the provision of Good Clinical Practice (GCP), Good Pharmacovigilance Practice (GVP), Good Laboratory Practice (GLP), Good Clinical Laboratory Practice (GcLP) and Computer System Validation (CSV) audits and QMS consultancy and regulatory Inspection preparation, GXP Engaged is able to deliver services across the entire lifecycle of a product development.
SwissPharmAudit® GmbH was established in 2010 and is known internationally for the excellent quality of its GxP auditing services. Adding to the GXP Auditing Group of companies, the acquisition brings further scale and breadth of expertise to the Northern European and Swiss markets, complementing GXP Engaged’s already established presence in the US, UK, European and Asian markets.
GXP Engaged is well-positioned to continue supporting clients with navigating an increasingly onerous and rigorously enforced regulatory environment. With support from Kester Capital, a UK-based Private Equity firm, GXP Engaged is building a global presence rapidly, both organically and through strategic acquisitions.
“At GXP Engaged, we are now able to deliver the highest quality services, globally, with an unrivalled responsiveness and scalability. Whether it’s a one-off, last minute “for cause” situation or a large global multicenter, multi-phase project, our expert team will engage with the same consummate competence. This is our unique differentiator as the clear market leader in GxP auditing services. We can have the right resources wherever and whenever they are needed.” said Ian Montague, CEO of GXP Engaged. “Our business model fosters consistent quality, continuous improvement and agile scalability. The global reach and depth of expertise we have built up enables us to partner with our clients most efficiently. Acceleration of growth in the strategically important US market is crucial for us as we consolidate our dominant market position. It also further strengthens our ability to provide our clients with the support they need in any location.”
Commenting on the acquisition, Stephanie M. Zingler, Managing Director and founder of SwissPharmAudit® GmbH, said, “We are delighted to have been acquired by GXP Engaged. We share the same reputation for quality, our cultures are highly compatible and I am confident that our valued clients will feel the benefits for many years to come, through access to more extensive resources and continued engagement with the highest quality auditors.”
GXP Engaged operates internationally, with offices in four primary locations - the UK, Germany, Austria and the United States of America. Following the acquisition, Stephanie M. Zingler has stepped into an advisory role and will support Ian Montague in his role as CEO.
